M&A Deal Summary |
|
|---|---|
| Date | 2023-02-13 |
| Target | Luminex Corp s Flow Cytometry & Imaging Business |
| Sector | Medical Products |
| Buyer(s) | Cytek |
| Sellers(s) | Luminex |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1992 |
| Sector | Life Science |
| Employees | 663 |
| Revenue | 200M USD (2024) |
Cytek is a cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with exquisite sensitivity. Cytek’s FSP platform includes its core instruments, the Aurora and Northern Lights systems, reagents, cell sorter, software, and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek was founded in 1992 and is based in Fremont, California.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| State: Texas M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-03 |
Tonbo Biosciences - Cell Analysis Business
San Diego, California, United States Tonbo Biosciences' Cell Analysis Business includes an extensive portfolio of life science research reagents related to cell preparation, flow cytometry, molecular immunology/PCR, and cell culture covering application areas across immunology, apoptosis, and immune profiling. Tonbo Biosciences' Cell Analysis Business is based in San Diego, California. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1995 |
| Sector | Medical Products |
| Employees | 1,325 |
| Revenue | 417M USD (2020) |
Luminex is a developer, manufacturer and marketer of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex was founded in 1995 and is based in Austin, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Texas M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-10-18 |
Merck KGaA - Flow Cytometry Portfolio
Darmstadt, Germany Merck KGaA - Flow Cytometry Portfolio includes Amnis, the market-leading family of imaging flow cytometry products for cell-based analysis, as well as their Guava portfolio of products, which are economical, high-performance systems based on microcapillary technologies. |
Buy | €63M |
